Literature DB >> 13986140

Studies on the etiology of carcinoma of the urinary bladder.

J M PRICE, R R BROWN.   

Abstract

Entities:  

Keywords:  BLADDER NEOPLASMS; OCCUPATIONAL DISEASES; TRYPTOPHAN

Mesh：

Substances：

Year:  1962        PMID： 13986140

Source DB:  PubMed          Journal:  Acta Unio Int Contra Cancrum        ISSN： 0365-3056


× No keyword cloud information.
  7 in total

Review 1.  Aspects of tryptophan metabolism in health and disease: a review.

Authors:  D P Rose
Journal:  J Clin Pathol       Date:  1972-01       Impact factor: 3.411

2.  Effect of 3-hydroxyanthranilic acid on the mitochondrial respiratory system.

Authors:  E Quagliariello; S Papa; C Saccone; A Alifano
Journal:  Biochem J       Date:  1964-04       Impact factor: 3.857

3.  The influence of sex, age, synthetic oestrogens, progestogens and oral contraceptives on the excretion of urinary tryptophan metabolites.

Authors:  G E Moursi; M H Abdel-Daim; N L Kelada; G A Abdel-Tawab; L H Girgis
Journal:  Bull World Health Organ       Date:  1970       Impact factor: 9.408

4.  Studies with tryptophan metabolites in vitro. Kynurenine metabolism in liver homogenates of normal and Schistosoma mansoni-infested mice.

Authors:  M S Amer; M H Abdel-Daim; G A Abdel-Tawab
Journal:  Biochem J       Date:  1967-08       Impact factor: 3.857

5.  Magnesium (and trace substance) deficiencies in the pathogenesis of cancer.

Authors:  M S Seelig
Journal:  Biol Trace Elem Res       Date:  1979-12       Impact factor: 3.738

6.  Studies with tryptophan metabolites in vitro. Kynurenine metabolism in kidneys of mice infested with Schistosoma mansoni.

Authors:  M S Amer; M H Abdel-Daim; G A Abdel-Tawab
Journal:  Biochem J       Date:  1968-10       Impact factor: 3.857

7.  The concentration of free and conjugated 3-hydroxyanthranilic acid in the urine of bladder tumour patients before and after therapy, measured with an enzymatic method.

Authors:  F A Teulings; W Fokkens; J G Kaalen; B van der Werf-Messing
Journal:  Br J Cancer       Date:  1973-04       Impact factor: 7.640
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.